Vaccines as a Strategy to Combat AMR

Vaccines as a Strategy to Combat Antimicrobial Resistance (AMR) highlight the critical role of immunization in preventing infections and reducing the need for antimicrobial use. By lowering the incidence of bacterial and viral diseases, vaccines indirectly decrease antibiotic consumption and limit the emergence and spread of resistant pathogens.

The session will explore how existing vaccines (such as those for pneumococcal infections, influenza, and HPV) have already contributed to reducing infection rates and antibiotic prescriptions globally. Preventing infections at the source minimizes the need for treatment and helps preserve the effectiveness of current antimicrobial drugs.

 

    Related Conference of Vaccines as a Strategy to Combat AMR

    September 14-15, 2026

    6th International Conference on Pharmaceutical Chemistry

    Paris, France
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France
    November 26-27, 2026

    5th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    November 26-27, 2026

    5th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    December 14-15, 2026

    5th Global Summit on Pharmaceutical Research

    Paris, France
    January 26-27, 2027

    22nd Annual Meet on Pharmaceutical Sciences

    Paris, France
    February 15-16, 2027

    23rd Annual Congress on Pharmacology and Toxicology

    Paris, France
    April 08-09, 2027

    21st World Drug Delivery Summit

    Vienna, Austria
    April 27-28, 2027

    10th European Biopharma Congress

    Paris, France
    April 27-28, 2027

    19th World Drug Delivery Summit

    Paris, France

    Vaccines as a Strategy to Combat AMR Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in